Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Szabo B et al. |
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. |
2006 |
J. Physiol. (Lond.) |
pmid:16973696
|
Kasai HF et al. |
Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. |
2006 |
Anal Sci |
pmid:16837740
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
van der Stelt M et al. |
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. |
2006 |
Cell. Mol. Life Sci. |
pmid:16732431
|
Panikashvili D et al. |
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. |
2006 |
Neurobiol. Dis. |
pmid:16364651
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). |
2006 |
Bioorg. Med. Chem. |
pmid:16403642
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Oka S et al. |
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. |
2006 |
J. Immunol. |
pmid:17142782
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Malcher-Lopes R et al. |
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. |
2006 |
J. Neurosci. |
pmid:16775153
|
Kishimoto S et al. |
Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. |
2006 |
Int. Arch. Allergy Immunol. |
pmid:16772720
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
Yoshida T et al. |
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. |
2006 |
J. Neurosci. |
pmid:16672646
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Katona I et al. |
Molecular composition of the endocannabinoid system at glutamatergic synapses. |
2006 |
J. Neurosci. |
pmid:16723519
|
Kurabayashi M et al. |
2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. |
2005 Jan-Feb |
J Invest Surg |
pmid:15804949
|
Gokoh M et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. |
2005 |
Biochem. J. |
pmid:15456404
|
Harada N et al. |
Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. |
2005 |
J Nippon Med Sch |
pmid:15834207
|
Oka S et al. |
Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. |
2005 |
J. Biol. Chem. |
pmid:15749716
|
Kishimoto S et al. |
Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. |
2005 |
J. Biochem. |
pmid:15749836
|
Julien B et al. |
Antifibrogenic role of the cannabinoid receptor CB2 in the liver. |
2005 |
Gastroenterology |
pmid:15765409
|
Kaplan BL et al. |
2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. |
2005 |
J. Leukoc. Biol. |
pmid:15774549
|
Lauckner JE et al. |
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16365309
|
Hill MN et al. |
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. |
2005 |
Eur. J. Pharmacol. |
pmid:16324692
|
Gokoh M et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes. |
2005 |
FEBS Lett. |
pmid:16288744
|
Iturralde M et al. |
Characterization of the lipolytic pathways that mediate free fatty acid release during Fas/CD95-induced apoptosis. |
2005 |
Apoptosis |
pmid:16215685
|
Safo PK and Regehr WG |
Endocannabinoids control the induction of cerebellar LTD. |
2005 |
Neuron |
pmid:16301180
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Maejima T et al. |
Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. |
2005 |
J. Neurosci. |
pmid:16033892
|
Panikashvili D et al. |
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. |
2005 |
J. Cereb. Blood Flow Metab. |
pmid:15729296
|
Gopez JJ et al. |
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. |
2005 |
Neurosurgery |
pmid:15730585
|
Zhao Q et al. |
2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. |
2005 |
J. Biol. Chem. |
pmid:15886210
|
Rouzer CA and Marnett LJ |
Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus. |
2005 |
J. Biol. Chem. |
pmid:15917246
|
Nithipatikom K et al. |
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15919052
|
Darmani NA et al. |
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. |
2005 |
Neuropharmacology |
pmid:15921709
|
Kola B et al. |
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. |
2005 |
J. Biol. Chem. |
pmid:15899896
|
Shoemaker JL et al. |
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15901805
|
Saario SM et al. |
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. |
2005 |
Chem. Biol. |
pmid:15975510
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|